We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Integrating Cardiovascular Risk Biomarkers Aids in Detection of ‘Inflammaging’

By LabMedica International staff writers
Posted on 31 Oct 2024
Print article
Image: Integration of inflammaging biomarkers with organ function markers (Photo courtesy of Aging; https://doi.org/10.18632/aging.206136)
Image: Integration of inflammaging biomarkers with organ function markers (Photo courtesy of Aging; https://doi.org/10.18632/aging.206136)

Cardiovascular diseases (CVD) continue to be the leading cause of death globally, responsible for nearly one-third of all fatalities worldwide. Traditionally, risk assessment for CVD has focused on well-established factors associated with atherosclerosis, such as demographics, lifestyle choices like smoking and physical activity, and health conditions including diabetes, hypertension, and obesity. Biomarkers, particularly non-HDL cholesterol, have also been crucial in identifying individuals at risk. Nonetheless, there remains a significant residual cardiovascular risk even after managing these known factors, indicating that additional, unexamined contributors to cardiovascular health may exist. In a new paper published in Aging, researchers have investigated how the integration of specific cardiovascular biomarkers could assist in evaluating this residual inflammatory risk, especially in the context of aging-related inflammation, known as "inflammaging."

The study, conducted by researchers from Marche Polytechnic University (UNIVPM, Ancona, Italy) and IRCCS INRCA (Ancona, Italy), focused on biomarkers such as high-sensitivity C-reactive protein (hs-CRP), high-sensitivity cardiac troponin (hs-cTn), and natriuretic peptides, which are valuable indicators of both inflammatory burden and early cardiovascular risk. The researchers propose a more comprehensive biomarker-based strategy for assessing cardiovascular risk that includes two distinct dimensions. The first set of biomarkers—comprising cytokines, immune cell phenotypes, and mediators released by senescent or dysfunctional cells, known as the senescence-associated secretory phenotype (SASP)—can indicate the overall burden of inflammaging and, by extension, residual inflammatory risk. The second set, which includes hs-cTn and natriuretic peptides (NPs), functions as surrogate markers that reflect the influence of inflammaging on organ function.

Importantly, the biomarkers in this second group can also serve as endpoints, as numerous studies have shown their responsiveness to therapeutic interventions. Establishing a mediating relationship between these two groups of biomarkers would enhance the understanding of the mechanistic connections between inflammaging and age-related organ dysfunction and disease. In summary, the researchers demonstrated that combining markers of chronic inflammation with cardiac health indicators provides a more comprehensive view of cardiovascular risk, highlighting the effects of aging-related inflammation, or "inflammaging," on heart health. They suggest that this approach could pave the way for targeted interventions in aging populations.

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Automated Blood Typing System
IH-500 NEXT
New
Adenovirus Detection Kit
REALQUALITY RQ-ADENO
New
Hepato Fibrosis Assays
Hepato Fibrosis Assays

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Immunology

view channel
Image: An immune response is initiated when an antigen-presenting cell (pink) presents foreign material to a T-cell (blue) (Photo courtesy of JAX)

Advanced Imaging Method Maps Immune Cell Connections to Predict Cancer Patients Survival

A growing tumor is influenced not only by the tumor cells themselves but also by the surrounding tissue, which alters its biology. Immune cells communicate by transferring vital signaling proteins to their... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image: LMU’s Professor Frederick Klauschen developed the novel approach that can improve diagnostic accuracy (Photo courtesy of LMU Munich)

AI Tool Uses Imaging Data to Detect Less Frequent GI Diseases

Artificial intelligence (AI) is already being utilized in various medical fields, demonstrating significant potential in aiding doctors in diagnosing diseases through imaging data. However, training AI... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.